The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126783032 12678303 2 F 20160727 20160830 20160823 20160907 EXP IT-MINISAL02-371221 IT-MYLANLABS-2016M1034499 MYLAN 0.00 Y 0.00000 20160907 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126783032 12678303 1 PS SIMVASTATIN. SIMVASTATIN 1 UNK Y 90868
126783032 12678303 2 I CITALOPRAM CITALOPRAM HYDROBROMIDE 1 UNK Y 0
126783032 12678303 3 I ACETYLSALICYLIC ACID ASPIRIN 1 100 MG, QD Y 0 100 MG QD
126783032 12678303 4 I CLEXANE T ENOXAPARIN SODIUM 1 6000 IU, QD Y U 0 6000 IU QD
126783032 12678303 5 SS HEPARIN HEPARIN SODIUM 1 UNK U U 0
126783032 12678303 6 C MADOPAR BENSERAZIDE HYDROCHLORIDELEVODOPA 1 UNK 0
126783032 12678303 7 C RENVELA SEVELAMER CARBONATE 1 UNK 0
126783032 12678303 8 C EPOETIN ZETA ERYTHROPOIETIN 1 UNK 0
126783032 12678303 9 C HUMALOG INSULIN LISPRO 1 UNK 0
126783032 12678303 10 C LANTUS INSULIN GLARGINE 1 UNK 0
126783032 12678303 11 C TAVOR (LORAZEPAM) LORAZEPAM 1 UNK 0
126783032 12678303 12 C LERCANIDIPINE LERCANIDIPINE 1 UNK 0
126783032 12678303 13 C ALLOPURINOL. ALLOPURINOL 1 UNK 0
126783032 12678303 14 C CETIRIZINE CETIRIZINE HYDROCHLORIDE 1 UNK 0
126783032 12678303 15 C MONTELUKAST MONTELUKAST SODIUM 1 UNK 0
126783032 12678303 16 C SODIUM BICARBONATE. SODIUM BICARBONATE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126783032 12678303 1 Product used for unknown indication
126783032 12678303 2 Product used for unknown indication
126783032 12678303 3 Product used for unknown indication
126783032 12678303 4 Product used for unknown indication
126783032 12678303 5 Product used for unknown indication
126783032 12678303 6 Product used for unknown indication
126783032 12678303 7 Product used for unknown indication
126783032 12678303 8 Product used for unknown indication
126783032 12678303 9 Product used for unknown indication
126783032 12678303 10 Product used for unknown indication
126783032 12678303 11 Product used for unknown indication
126783032 12678303 12 Product used for unknown indication
126783032 12678303 13 Product used for unknown indication
126783032 12678303 14 Product used for unknown indication
126783032 12678303 15 Product used for unknown indication
126783032 12678303 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126783032 12678303 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126783032 12678303 Anaemia
126783032 12678303 Drug interaction
126783032 12678303 Peritoneal haemorrhage
126783032 12678303 Spontaneous haematoma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found